Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Jun 4, 2010


GE Healthcare launched last week its DeCyder 2D 7.1 SPN software package for the characterization and quantitation of host cell proteins – a quality assurance parameter used in biopharmaceutical work.

The software provides an antibody-independent method of directly comparing target protein/HCP profiles between samples taken at various steps of biopharmaceutical processing, the company said in a statement.

OriGene Technologies announced last week at the 2010 American Society for Mass Spectrometry conference the production of over 5,000 heavy isotope labeled human proteins to be used as internal standards for SRM and MRM mass spectrometry.

The newly released protein standards will allow for more accurate targeted protein quantitation compared to heavy labeled AQUA peptides, the company said in a statement.

AnaSpec introduced this week its new Rhodamine 110 Labeled GO Peptides designed for the study of proteases like cysteine aspartate-specific proteases and serine proteases.

The Rhodamine 110 Labeled GO Peptides are generally cell permeable, making them useful in intact cells for applications like flow cytometry. Because Rh110 emits in the green range, autofluorescence interference from cellular components is minimal, the company said in a statement.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.